Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4ABBVIE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Medlab Asia & Asia Health
Not Confirmed

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : 8481598

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Delist Requested :

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2031-03-02

Abbvie Company Banner

02

arrow
Medlab Asia & Asia Health
Not Confirmed

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : 8481598

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Delist Requested :

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2031-03-02

Abbvie Company Banner

03

arrow
Medlab Asia & Asia Health
Not Confirmed

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : 8481598

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Delist Requested :

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2031-03-02

Abbvie Company Banner

04

arrow
Medlab Asia & Asia Health
Not Confirmed

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : 8481598

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Delist Requested :

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2031-03-02

Abbvie Company Banner